Chennai, India

Maheswaran Sivasamban Karatholuvhu

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 7.7

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Periyar Nagar, IN (2014)
  • Chennai, IN (2014 - 2017)
  • Bengaluru, IN (2018 - 2019)

Company Filing History:


Years Active: 2014-2019

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Maheswaran Sivasamban Karatholuvhu: Innovator in Kinase Inhibitors

Introduction

Maheswaran Sivasamban Karatholuvhu is a prominent inventor based in Chennai, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of kinase inhibitors. With a total of 8 patents to his name, he has established himself as a key figure in pharmaceutical innovation.

Latest Patents

Karatholuvhu's latest patents include groundbreaking work on fused pyridines as kinase inhibitors. This patent focuses on compounds that can inhibit AAK1 (adaptor associated kinase 1), along with compositions comprising such compounds and methods for their application. Another notable patent involves quinoline-based kinase inhibitors, which are directed towards compounds that can inhibit AAKI (adaptor associated kinase 1), along with their respective compositions and methods.

Career Highlights

He is currently employed at Bristol-Myers Squibb Company, where he continues to push the boundaries of drug discovery and development. His work has been instrumental in advancing therapeutic options for various diseases.

Collaborations

Throughout his career, Karatholuvhu has collaborated with esteemed colleagues, including Carolyn Diane Dzierba and Joanne J Bronson. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Maheswaran Sivasamban Karatholuvhu is a distinguished inventor whose work in kinase inhibitors has the potential to impact the pharmaceutical industry significantly. His contributions continue to pave the way for new therapeutic advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…